After the FDA rejected its proposed MDMA treatment, Lykos Therapeutics is laying off 75 percent of its staff and its founder has left the company.
https://www.wired.com/story/where-does-psychedelic-assisted-therapy-go-next-mdma-fda-lykos/
https://www.wired.com/story/where-does-psychedelic-assisted-therapy-go-next-mdma-fda-lykos/